Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High levels of LIGHT/TNFSF14 in patients with Prader-Willi syndrome.
Faienza MF, Brunetti G, Fintini D, Grugni G, Wasniewska MG, Crinò A, D'Amato G, Piacente L, Oranger A, Dicarlo M, Colucci S, Grano M. Faienza MF, et al. Among authors: crino a. J Endocrinol Invest. 2023 Sep;46(9):1901-1909. doi: 10.1007/s40618-023-02050-2. Epub 2023 Mar 14. J Endocrinol Invest. 2023. PMID: 36917420 Free PMC article.
Multicentric Italian case-control study on 25OH vitamin D levels in children and adolescents with Prader-Willi syndrome.
Panfili FM, Convertino A, Grugni G, Mazzitelli L, Bocchini S, Crinò A, Campana G, Cappa M, Delvecchio M, Faienza MF, Licenziati MR, Mariani M, Osimani S, Pajno R, Patti G, Rutigliano I, Sacco M, Scarano E, Fintini D; on behalf of the Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (ISPED). Panfili FM, et al. Among authors: crino a. J Endocrinol Invest. 2023 Jul;46(7):1397-1406. doi: 10.1007/s40618-022-01990-5. Epub 2023 Jan 28. J Endocrinol Invest. 2023. PMID: 36708456
Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli MC, Crinò A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Suppa M, Sulli N, De Mattia G, Faldetta MR. Pozzilli P, et al. Among authors: crino a. Eur J Endocrinol. 1997 Sep;137(3):234-9. doi: 10.1530/eje.0.1370234. Eur J Endocrinol. 1997. PMID: 9330586 Clinical Trial.
A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI).
Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E, Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crinò A, Corbi S, Spera S, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N, Cervoni M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P, et al. Visalli N, et al. Among authors: crino a. Diabetes Metab Res Rev. 1999 May-Jun;15(3):181-5. doi: 10.1002/(sici)1520-7560(199905/06)15:3<181::aid-dmrr31>3.0.co;2-h. Diabetes Metab Res Rev. 1999. PMID: 10441040 Clinical Trial.
No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
Pozzilli P, Pitocco D, Visalli N, Cavallo MG, Buzzetti R, Crinò A, Spera S, Suraci C, Multari G, Cervoni M, Manca Bitti ML, Matteoli MC, Marietti G, Ferrazzoli F, Cassone Faldetta MR, Giordano C, Sbriglia M, Sarugeri E, Ghirlanda G. Pozzilli P, et al. Among authors: crino a. Diabetologia. 2000 Aug;43(8):1000-4. doi: 10.1007/s001250051482. Diabetologia. 2000. PMID: 10990077 Clinical Trial.
133 results